Acomplia in Canada

…  FDA approval mechanisms, and the drug has not yet been submitted for Canadian evaluation by the French drug …

About Rimonabant

…  wrong food choices have all added their share to higher BMI numbers and wider waist circumferences. With the world becoming a global …

Rimnobant – Generic Acomplia (Rimoslim)

…  is recommended for individuals who have a Body Mass Index (BMI) of 30 kg/m2 or greater and associated complications including type 2 …

Obesity and Rimonabant

…  body mass index greater than 30 kg/m2, or patients with a BMI greater than 27 kg/m2 with associated risk factors, such as type 2 diabetes …

Rimonabant and other weight loss medication

…  men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all …

Obesity and surgery

…  surgery may be an option for people with extreme obesity (BMI of 40 or greater) when other treatments have failed. It’s also an option for people with a BMI of 35 or greater who have life-threatening conditions such as: • Severe …

Rimonabant – measuring obesity

…  numbers should not be confused with the body mass index (BMI), however, which is more commonly used by health care professionals to …  person may be classified obese when he or she is not. The BMI is less likely to misidentify a person’s appropriate weight-for-height …

Rimonabant Side Effects

…  men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all …

Rimonabant not Rimonaband

…  numbers should not be confused with the body mass index (BMI), however, which is more commonly used by health care professionals to …

Rimonabant Acomplia

…  men aged 55-64 years are clinically obese or overweight (BMI >25) and almost 70% of women in this age group. One in five of all …  body mass index greater than 30 kg/m2, or patients with a BMI greater than 27 kg/m2 with associated risk factors, such as type 2 diabetes …